PAUL J HASTINGS Insider Trading $PCRX Pacira BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL J HASTINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL J HASTINGS. PAUL J HASTINGS is President & CEO in QLT INC/BC ($QLTI) and Chairman & CEO in OncoMed Pharmaceuticals Inc ($OMED) and Chief Executive Officer in OncoMed Pharmaceuticals Inc ($OMED) and Director in PROTEON THERAPEUTICS INC ($PRTO) and Director in Pacira Pharmaceuticals, Inc. ($PCRX) and Director in Relypsa Inc ($RLYP) and Chief Executive Officer in Nkarta, Inc. ($NKTX) and See Remarks in Nkarta, Inc. ($NKTX).
PAUL J HASTINGS in Pacira BioSciences, Inc.
Trading Symbol: PCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J HASTINGS: Director
Holdings: 6,552 shares
Current Value: $273,546
Latest Transaction: Jun 11 2021
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL J HASTINGS in Pacira BioSciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NKTX, NVLN, OMED, PCRX, TARA, RLYP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 60.96 | 7,626 | 464,881 | 7,626 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,066 | 0 | 6,552 | 5.5 K to 6.6 K (+19.43 %) |
Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 3,000 | 41,940 | 0 | |
Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 65.88 | 3,000 | 197,640 | 6,116 | 9.1 K to 6.1 K (-32.91 %) |
Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 3,000 | 41,940 | 9,116 | 6.1 K to 9.1 K (+49.05 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,260 | 0 | 6,116 | 4.9 K to 6.1 K (+25.95 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 47.46 | 2,025 | 96,107 | 4,856 | 6.9 K to 4.9 K (-29.43 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 4,134 | 0 | 6,881 | 2.7 K to 6.9 K (+150.49 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 42.66 | 782 | 33,360 | 2,747 | 3.5 K to 2.7 K (-22.16 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 4,134 | 0 | 6,881 | 2.7 K to 6.9 K (+150.49 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 42.66 | 782 | 33,360 | 2,747 | 3.5 K to 2.7 K (-22.16 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 782 | 0 | 3,529 | 2.7 K to 3.5 K (+28.47 %) |
Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 33.90 | 771 | 26,137 | 2,747 | 3.5 K to 2.7 K (-21.92 %) |
Aug 24 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 36.15 | 1,044 | 37,741 | 3,518 | 4.6 K to 3.5 K (-22.88 %) |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,357 | 0 | 4,562 | 3.2 K to 4.6 K (+42.34 %) |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,488 | 0 | 3,205 | 1.7 K to 3.2 K (+86.66 %) |
Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 46.95 | 1,136 | 53,335 | 1,717 | 2.9 K to 1.7 K (-39.82 %) |
Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 10.81 | 1,000 | 10,810 | 0 | |
Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 2,000 | 27,960 | 3,000 | |
Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 60.00 | 3,000 | 180,000 | 2,853 | 5.9 K to 2.9 K (-51.26 %) |
Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 10.81 | 1,000 | 10,810 | 5,853 | 4.9 K to 5.9 K (+20.61 %) |
Feb 22 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 2,000 | 27,960 | 4,853 | 2.9 K to 4.9 K (+70.10 %) |
Nov 24 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 10.81 | 3,000 | 32,430 | 1,000 | |
Nov 24 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 60.00 | 3,000 | 180,000 | 2,853 | 5.9 K to 2.9 K (-51.26 %) |
Nov 24 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 10.81 | 3,000 | 32,430 | 5,853 | 2.9 K to 5.9 K (+105.15 %) |
Aug 19 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 10.81 | 3,000 | 32,430 | 4,000 | |
Aug 19 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 60.02 | 3,000 | 180,060 | 2,853 | 5.9 K to 2.9 K (-51.26 %) |
Aug 19 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 10.81 | 3,000 | 32,430 | 5,853 | 2.9 K to 5.9 K (+105.15 %) |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 2,000 | 0 | 2,853 | 853 to 2.9 K (+234.47 %) |
Apr 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 2,500 | 34,950 | 5,000 | |
Apr 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 88.00 | 2,500 | 220,000 | 853 | 3.4 K to 853 (-74.56 %) |
Apr 14 2015 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 2,500 | 34,950 | 3,353 | 853 to 3.4 K (+293.08 %) |
Page: 1